448 related articles for article (PubMed ID: 25447194)
1. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
[TBL] [Abstract][Full Text] [Related]
2. Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa.
Serra I; Scorciapino MA; Manzo G; Casu M; Rinaldi AC; Attoub S; Mechkarska M; Conlon JM
Peptides; 2014 Nov; 61():114-21. PubMed ID: 25241629
[TBL] [Abstract][Full Text] [Related]
3. Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities.
Manzo G; Scorciapino MA; Srinivasan D; Attoub S; Mangoni ML; Rinaldi AC; Casu M; Flatt PR; Conlon JM
J Nat Prod; 2015 Dec; 78(12):3041-8. PubMed ID: 26606380
[TBL] [Abstract][Full Text] [Related]
4. An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.
Mechkarska M; Prajeep M; Radosavljevic GD; Jovanovic IP; Al Baloushi A; Sonnevend A; Lukic ML; Conlon JM
Peptides; 2013 Dec; 50():153-9. PubMed ID: 24172540
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.
Conlon JM; Prajeep M; Mechkarska M; Coquet L; Leprince J; Jouenne T; Vaudry H; King JD
Comp Biochem Physiol Part D Genomics Proteomics; 2013 Dec; 8(4):352-7. PubMed ID: 24212286
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activities of the host-defense peptide hymenochirin-1B.
Attoub S; Arafat H; Mechkarska M; Conlon JM
Regul Pept; 2013 Nov; 187():51-6. PubMed ID: 24185042
[TBL] [Abstract][Full Text] [Related]
7. A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae).
Conlon JM; Mechkarska M; Radosavljevic G; Attoub S; King JD; Lukic ML; McClean S
Peptides; 2014 Jun; 56():132-40. PubMed ID: 24704757
[TBL] [Abstract][Full Text] [Related]
8. Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.
Attoub S; Mechkarska M; Sonnevend A; Radosavljevic G; Jovanovic I; Lukic ML; Conlon JM
Peptides; 2013 Jan; 39():95-102. PubMed ID: 23159562
[TBL] [Abstract][Full Text] [Related]
9. Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria.
Conlon JM; Mechkarska M; Arafat K; Attoub S; Sonnevend A
J Pept Sci; 2012 Apr; 18(4):270-5. PubMed ID: 22392897
[TBL] [Abstract][Full Text] [Related]
10. Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent.
Conlon JM; Mechkarska M; Prajeep M; Arafat K; Zaric M; Lukic ML; Attoub S
Amino Acids; 2013 Feb; 44(2):715-23. PubMed ID: 22965637
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae).
Conlon JM; Musale V; Attoub S; Mangoni ML; Leprince J; Coquet L; Jouenne T; Abdel-Wahab YHA; Flatt PR; Rinaldi AC
J Pept Sci; 2017 Oct; 23(10):769-776. PubMed ID: 28699258
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens.
McLean DT; McCrudden MT; Linden GJ; Irwin CR; Conlon JM; Lundy FT
Regul Pept; 2014 Nov; 194-195():63-8. PubMed ID: 25447193
[TBL] [Abstract][Full Text] [Related]
13. Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).
Conlon JM; Raza H; Coquet L; Jouenne T; Leprince J; Vaudry H; King JD
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):150-4. PubMed ID: 19379837
[TBL] [Abstract][Full Text] [Related]
14. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
Eley A; Ibrahim M; Kurdi SE; Conlon JM
Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
[TBL] [Abstract][Full Text] [Related]
15. Feleucin-BO1: a novel antimicrobial non-apeptide amide from the skin secretion of the toad, Bombina orientalis, and design of a potent broad-spectrum synthetic analogue, feleucin-K3.
Hou X; Du Q; Li R; Zhou M; Wang H; Wang L; Guo C; Chen T; Shaw C
Chem Biol Drug Des; 2015 Mar; 85(3):259-67. PubMed ID: 25056849
[TBL] [Abstract][Full Text] [Related]
16. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs.
Conlon JM; Hunter L; Attoub S; Casciaro B; Mechkarska M; Abdel-Wahab YHA
J Pept Sci; 2023 Apr; 29(4):e3463. PubMed ID: 36426386
[TBL] [Abstract][Full Text] [Related]
18. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.
Pál T; Sonnevend A; Galadari S; Conlon JM
Regul Pept; 2005 Jul; 129(1-3):85-91. PubMed ID: 15927702
[TBL] [Abstract][Full Text] [Related]
19. Effects of tigerinin peptides on cytokine production by mouse peritoneal macrophages and spleen cells and by human peripheral blood mononuclear cells.
Pantic JM; Mechkarska M; Lukic ML; Conlon JM
Biochimie; 2014 Jun; 101():83-92. PubMed ID: 24412102
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant Acinetobacter baumannii.
Conlon JM; Ahmed E; Condamine E
Chem Biol Drug Des; 2009 Nov; 74(5):488-93. PubMed ID: 19793185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
